These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1426605)

  • 1. Molecular pathology of Alzheimer's disease in sporadic and familial Alzheimer's disease with mutations in the amyloid precursor protein.
    Hanger DP; Mann DM; Neary D; Anderton BH
    Biochem Soc Trans; 1992 Aug; 20(3):642-5. PubMed ID: 1426605
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology.
    Lantos PL; Luthert PJ; Hanger D; Anderton BH; Mullan M; Rossor M
    Neurosci Lett; 1992 Mar; 137(2):221-4. PubMed ID: 1584463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeletal abnormalities in Alzheimer's disease.
    Lovestone S; Anderton B
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):883-8. PubMed ID: 1467582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Annu Rev Cell Biol; 1994; 10():373-403. PubMed ID: 7888181
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.
    Tcw J; Goate AM
    Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piecing together Alzheimer's.
    St George-Hyslop PH
    Sci Am; 2000 Dec; 283(6):76-83. PubMed ID: 11103462
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular pathology of Alzheimer's disease.
    Carter J; Anderton B
    Br J Hosp Med; 1994 May 18-31; 51(10):522-8. PubMed ID: 7921490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A century of Alzheimer's disease.
    Goedert M; Spillantini MG
    Science; 2006 Nov; 314(5800):777-81. PubMed ID: 17082447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 13. Tau pathology in a case of familial Alzheimer's disease with a valine to glycine mutation at position 717 in the amyloid precursor protein.
    Hanger DP; Mann DM; Neary D; Anderton BH
    Neurosci Lett; 1992 Oct; 145(2):178-80. PubMed ID: 1465214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible fetal antigen of Mr 70,000 in neurofibrillary tangles.
    Morishima-Kawashima M; Arai T; Ogawara M; Takio K; Titani K; Saitoh T; Kosik KS; Ihara Y
    Brain Res; 1991 Jul; 554(1-2):316-20. PubMed ID: 1933313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurochemistry of Alzheimer's disease.
    Blennow K; Cowburn RF
    Acta Neurol Scand Suppl; 1996; 168():77-86. PubMed ID: 8997425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.
    Murrell J; Farlow M; Ghetti B; Benson MD
    Science; 1991 Oct; 254(5028):97-9. PubMed ID: 1925564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
    Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
    Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.